TITLE 856 INDIANA BOARD OF PHARMACY

Under IC 4-22-2-23, the Indiana Board of Pharmacy intends to adopt a rule concerning the following:

OVERVIEW: Adds 856 IAC 1-43 concerning ephedrine and pseudoephedrine. The rule will establish requirements concerning the sale of products containing ephedrine or pseudoephedrine by pharmacists. The rule will establish requirements regarding "conversion resistant" and "extraction resistant" products containing ephedrine or pseudoephedrine. Public comments are invited and may be directed to the Indiana Board of Pharmacy c/o Darren R. Covington, J.D., Director, 402 West Washington Street, Room W072, Indianapolis, Indiana 46204 or by email to dcovington@pla.in.gov. Statutory authority: IC 25-26-13-4; IC 35-48-4-14.3.

For purposes of IC 4-22-2-28.1, the Small Business Regulatory Coordinator for this rule is:

Darren R. Covington, J.D.

Indiana Professional Licensing Agency

Indiana Government Center South

402 West Washington Street, Room W072

Indianapolis, IN 46204

(317) 234-2011

dcovington@pla.in.gov

For purposes of IC 4-22-2-28.1, the Small Business Ombudsman designated by IC 4-4-35-8 is:

Katelyn Colclazier

Small Business Ombudsman

Indiana Economic Development Corporation

One North Capitol, Suite 700

Indianapolis, IN 46204

(317) 431-1560

kcolclazier@iedc.in.gov

Resources available to regulated entities through the small business ombudsman include the ombudsman's duties stated in IC 4-4-35-8, specifically IC 4-4-35-8(9), investigating and attempting to resolve any matter regarding compliance by a small business with a law, rule, or policy administered by a state agency, either as a party to a proceeding or as a mediator.

DIN: 20170614-IR-856170283NIA

Composed: May 04,2024 7:09:44PM EDT

A PDF version of this document.